Results 31 to 40 of about 33,525 (245)
Adiponectin as a novel biomarker of disease severity in alopecia areata
Scientific Reports, 2021 The frequent coexistence of obesity and metabolic syndrome in patients with alopecia areata may indicate the common pathogenetic pathway in these conditions with an important role of adipokines.
Anna Stochmal +6 more
doaj +1 more source
Baricitinib for alopecia areata
Journal of the Pakistan Medical Association, 2023 Alopecia areata is a disease in which an active immune response is triggered against the hair follicles, causing hair loss. The extent of this hair loss is proportional to the number of hair follicles attacked. Alopecia areata is classified into three types depending on the area of hair fall: alopecia areata, alopecia totalis, and alopecia universalis.
Hamza Imran, Farazul Hoda, Firzah Shakil
openaire +2 more sources
Tofacitinib in a Recalcitrant Case of Alopecia Areata
GAIMS Journal of Medical Sciences, 2022 Alopecia areata (AA) is a non-cicatricial alopecia that is postulated to be a hair-specific autoimmune disease, with genetic factors playing a role in disease susceptibility and severity.
Mansi Pithadia +3 more
doaj +1 more source
Bitemporal alopecia areata [PDF]
, 2020 Alopecia areata has various clinical presentations, some of which have recognised prognostic significance. We report five cases of bitemporal alopecia areata, with involvement of the frontal hairline, the therapeutic approach for each case and possible ...
Lara Trindade de Carvalho +7 more
core +1 more source
Tofacitinib for treating severe alopecia areata: a case series
, 2022 Aims: To demonstrate the effectiveness and safety of oral tofacitinib in treating severe alopecia areata. Methods: We present a case series of four patients with severe alopecia areata treated with oral tofacitinib (Xeljanz) on compassionate supply ...
Sander, Christina, O'Bryen, John
core +1 more source
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done +6 more
doaj +1 more source
Alopecia areata: a new treatment plan
, 2011 Adel AlsantaliDepartment of Dermatology, King Fahd Armed Forces Hospital, Jeddah, Saudi ArabiaAbstract: Many therapeutic modalities have been used to treat alopecia areata, with variable efficacy and safety profiles.
Alsantali A, Adel Alsantali
core +1 more source
Cognitive-behavioural psychotherapy and alopecia areata
, 2017 Alopecia areata (also known as spot baldness) is a disease with multifactorial aetiology, including genetic, hormonal, autoimmune and psychological factors as well as nervous system disorders.
Marta Kuty-Pachecka
core +1 more source
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder that greatly impacts patients’ quality of life, and its management remains challenging. Tofacitinib is the first Janus kinase inhibitor to be approved for clinical use and is the most extensively studied. Several
Jundong Huang +5 more
doaj +1 more source
, 2015 Alopecia areata (AA) is a common, non-scarring alopecia that usually presents as well-circumscribed patches of sudden hair loss and affects 0.1-0.2% of the population. The aetiology of AA is thought to be both genetic and autoimmune in nature. One hundred and thirty-nine single nucleotide polymorphisms linked to AA have been identified in 8 regions of ...
Eshini Perera +2 more
openaire +3 more sources